Us Bancorp \De\ Meira G Tx Holdings PLC Transaction History

Us Bancorp \De\

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$5.04 - $8.6 $347 - $593	69 Added 11.79%	654 $3,000
Q4 2022 Feb 13, 2023	SELL	$5.8 - $8.98 $9,639 - $14,924	-1,662 Reduced 73.97%	585 $3,000
Q3 2022 Oct 27, 2022	BUY	$7.55 - $11.25 $9,029 - $13,455	1,196 Added 113.8%	2,247 $19,000
Q2 2022 Aug 01, 2022	SELL	$6.8 - $14.23 $5,412 - $11,327	-796 Reduced 43.1%	1,051 $8,000
Q1 2022 May 11, 2022	BUY	$13.42 - $23.38 $9,702 - $16,903	723 Added 64.32%	1,847 $26,000
Q4 2021 Feb 11, 2022	BUY	$12.78 - $23.74 $9,009 - $16,736	705 Added 168.26%	1,124 $27,000
Q3 2021 Nov 10, 2021	BUY	$11.73 - $16.08 $4,914 - $6,737	419 New	419 $6,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $283M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.